Stock MLYS MINERALYS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Mineralys Therapeutics, Inc.

Equities

MLYS

US6031701013

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
12.77 USD +2.82% Intraday chart for Mineralys Therapeutics, Inc. +4.67% +48.49%
16/05 Transcript : Mineralys Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 05:01 PM
09/05 Transcript : Mineralys Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Goldman Sachs Initiates Mineralys Therapeutics at Buy With $30 Price Target
MT
Credit Suisse Adjusts Mineralys Therapeutics' Price Target to $37 From $38, Keeps Outperform Rating
MT
Credit Suisse Adjusts Mineralys Therapeutics' Price Target to $38 From $40, Keeps Outperform Rating
MT
Evercore ISI Starts Mineralys Therapeutics at Outperform
MT
Wells Fargo Starts Mineralys Therapeutics at Overweight With $27 Price Target
MT
Guggenheim Starts Mineralys Therapeutics at Buy With $32 Price Target
MT
BofA Securities Starts Mineralys Therapeutics at Buy With $39 Price Target
MT
Credit Suisse Starts Mineralys Therapeutics at Outperform With $40 Price Target, Says Potential Near-Term Partnership Could Boost Stock Value
MT
Stifel Starts Mineralys Therapeutics at Buy With $45 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MLYS Stock
  4. News Mineralys Therapeutics, Inc.
  5. Analyst Reco.